Pharmaceuticals

Rexahn Pharmaceuticals Presents Additional Data for Supinoxin for the …
"There is an accumulating body of in vitro and in vivo evidence suggesting a potential role for Supinoxin in the treatment of TNBC - a particularly aggressive and often difficult-to-treat form of breast cancer, which comprises approximately 20% of new ... [...]
4
Like
Save
Progenics Pharmaceuticals Sets First Quarter 2016 Financial Results Call for May 5
TARRYTOWN, N.Y., April 21, 2016 (GLOBE NEWSWIRE) -- Progenics Pharmaceuticals, Inc., (Nasdaq:PGNX), an oncology company focused on developing innovative ways to target and treat prostate cancer, announced today that it will host a conference call ... [...]
5
Like
Save
Glenmark Pharmaceuticals introduce EMI scheme for cancer treatment drugs
Glenmark Pharmaceuticals has rolled out an EMI scheme for cancer patients in order to help them continue the treatment and meet the high cost of medication. The Mumbai-based company has included its two drugs — Abirapro prescribed for prostate cancer ... [...]
1
Like
Save
OncoGenex Pharmaceuticals Resumes Trade – Plummeting 23% on Lung Cancer …
The companyÂ's product candidates include Custirsen that is in Phase III clinical development for the treatment in men with metastatic castrate-resistant prostate cancer, as well as in patients with non-small cell lung cancer; and Apatorsen, which is ... [...]
5
Like
Save
Progenics Pharmaceuticals begins Phase 3 study of 1404; prostate cancer …
This Phase 3 clinical trial is expected to enroll approximately 450 patients with newly diagnosed low-grade prostate cancer who are candidates for active surveillance, but nonetheless are planning to undergo radical prostatectomy. This multi-center ... [...]
7
Like
Save
Peregrine Pharmaceuticals Provides Update on Planned Expansion of Bavituximab …
In the first quarter of 2016, Peregrine plans to initiate two new Phase II clinical trials in breast and lung cancer in combination with current standard of care treatments including both chemotherapy and immuno-oncology agents. In addition, the ... [...]
1
Like
Save